Market Exploration: Non-Compressible Haemorrhage – Novel Technologies

AI Summary

This announcement pertains to a Market Exploration conducted by the Defense and Security Accelerator (DASA) on behalf of the Research and Clinical Innovation wing of the Surgeon General’s Department. The primary objective is to identify existing medical technologies that have reached a Technology Readiness Level (TRL) of 3 or higher. By engaging with industry and academic partners, the department aims to gain a comprehensive understanding of current market capabilities, which will subsequently inform future medical research, treatment protocols, and development strategies. Although the user prompt references regulatory inspections, the provided document describes a pre-procurement intelligence phase rather than a compliance audit; thus, there are no violations or inspection dates to report. The regulatory framework governing this activity falls under the UK Ministry of Defence’s procurement and innovation guidelines. Organizations possessing relevant clinical or surgical technologies are invited to participate to assist the Surgeon General’s Department in mapping the technological landscape. It is explicitly noted that this market exploration does not constitute a formal commitment to a future competition or funding cycle but serves as a strategic exercise to guide future capability planning. This proactive approach ensures that future military medical advancements are grounded in a realistic assessment of existing market maturity.